Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-11-21
2006-11-21
Qian, Celine (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C514S04400A
Reexamination Certificate
active
07138272
ABSTRACT:
The invention relates to gene transfer into human T cells using novel retroviral scFv cell targeting vectors and using these vectors for the treatment of T-cell-associated diseases.
REFERENCES:
patent: 2311602 (1999-06-01), None
patent: 197 52 854 (1999-07-01), None
patent: WO 96/36360 (1996-11-01), None
patent: WO 98/51787 (1998-11-01), None
Verma et al. Gene therapy-promises, problems and prospects, Nature, 1997, vol. 389, pp. 239-242.
Marshall, E. Gene therapy's growing pains. Science, 1995, vol. 269, p. 1050-1055.
Juengst, E.T. What next for human gene therapy? British Medical Journal, 2003, vol. 3326, pp. 1410-1411.
Rubanyi, G.M. The future of gene therapy. Molecularr Aspects of Medicine, 2001, vol. 22, pp. 113-142.
Eck et al. Goodman and Gilman's The pharmacological basis of therapeutics, 1996, McGraw-Hill, NY, 9th Edition, Chapter 5, pp. 77-100.
Ross et. Gene therapy in the United States: A five-year staus report. Human Gene therapy, 1996, vol. 7, pp. 1781-1790.
Marusich et al. Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects cells from HIV-1 infection. Virology (2005, vol. 332, pp. 258-271.
Galanis et al. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crtical Reviews in Oncology and Hematology (2001) vol. 38, pp. 177-192.
Karavanas et al. Cell targeting by murine retroviral vectors. Crtical Reviews in Oncology and Hematology (1998) vol. 28, pp. 7-30.
Anderson, “Human Gene Therapy”,Science, vol. 256:808-813 (1992).
Chang et al., “Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1”,Gene Therapy, vol. 1:208-216 (1994).
Chu et al., “Toward Highly Efficient Cell-Type-Specific Gene Transfer with Retroviral Vectors Displaying Single-Chain Antibodies”,J. Virol., vol. 71:720-725 (1997).
Chu et al., “Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins”,Gene Therapy, vol. 1:292-299 (1994).
Cosset et al., “Retroviral Retargeting by Envelopes Expressing an N-Terminal Binding Domain”,J. Virol., vol. 69:6314-6322 (1995).
Duan et al., “Intracellular Immunization Against HIV-1 Infection of Human T Lymphocytes: Utility of Anti-Rev Single-Chain Variable Fragments”,Human Gene Therapy, vol. 6:1561-1573 (1995).
Dornburg, “Reticuloendotheliosis viruses and derived vectors”,Gene Therapy, vol. 2:301-310 (1995).
Engelstadter et al., “Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library”,Human Gene Therapy, vol. 11:293-303 (2000).
Huston et al., “Protein Engineering of Single-Chain Fv Analogs and Fusion Proteins”,Methods in Enzymology, vol. 203:46-88 (1991).
Jiang et al., “Cell-Type-Specific Gene Transfer into Human Cells with Retroviral Vectors That Display Single-Chain Antibodies”,J. Virol., vol. 72:10148-10156 (1998).
Kasahara et al., “Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor Interactions”,Science, vol. 266:1373-1375 (1994).
Leavitt et al., “Ex vivo transduction and expansion of CD4+lymphocytes from HIV+ donors: prelude to a ribozyme gene therapy trial”,Gene Therapy, vol. 3:599-606 (1996).
Levy-Mintz et al., “Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase”,J. Virol., vol. 70:8821-8832 (1996).
Macchi et al., “Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)”,Naturevol. 377:65-68 (1995).
Martinez et al., “Improved Retroviral Packaging Lines Derived from Spleen Necrosis Virus”,Virology, vol. 208:234-241 (1995).
Martinez et al., “Mapping of Receptor Binding Domains in the Envelope Protein of Spleen Necrosis Virus”,J. Virol.vol. 69:4339-4346 (1995).
Mikawa et al., “In VivoAnalysis of a New IacZ Retrovirus Vector Suitable for Cell Lineage Marking in Avian and Other Species”,Exp. Cell Res., vol. 195:516-523 (1991).
Morgan et al., “Analysis of the Functional and Host Range-Determining Regions of the Murine Exotropic and Amphotropic Retrovirus Envelope Proteins”,J. of Virol., vol. 67:4712-4721 (1993).
Ramenzani et al., “Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes”,Gene Therapy, vol. 4:861-867 (1997).
Russell et al., “Retroviral vectors displaying functional antibody fragments”,Nucleic Acids Res., vol. 21:1081-1085 (1993).
Schnierle et al., “Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells”,Proc. Natl. Acad. Sci. USA, vol. 94:8640-8645 (1997).
Smith et al., “Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys”,Antiviral Research, vol. 32:99-115 (1996).
Watanabe et al., “Construction of a Helper Cell Line for Avian Reticuloendotheliosis Virus Cloning Vectors”,Mol. Cell Biol., vol. 3:2241-2249 (1983).
Weiss, “Cellular Receptors and Viral Glycoproteins Involved in Retrovirus Entry”,The Retroviridaevol. 2:1-108 (1993).
Whitlow et al., “Single-Chain Fv Proteins and Their Fusion Proteins”,Methods: A Companion to Methods Enzymol., vol. 2:97-105 (1991).
Yu et al., “Gene Therapy for Metastatic Brain Tumors by Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Cells”,Human Gene Therapy, vol. 8:1065-1072 (1997).
Cichutek Klaus
Engelstaedter Martin
Bundesrepublik Deutschland
Garvey Tara L.
Qian Celine
LandOfFree
Gene transfer in human lymphocytes using retroviral scFv... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene transfer in human lymphocytes using retroviral scFv..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene transfer in human lymphocytes using retroviral scFv... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621901